1. Home
  2. VIGL vs SNCR Comparison

VIGL vs SNCR Comparison

Compare VIGL & SNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIGL
  • SNCR
  • Stock Information
  • Founded
  • VIGL 2020
  • SNCR 2000
  • Country
  • VIGL United States
  • SNCR United States
  • Employees
  • VIGL N/A
  • SNCR N/A
  • Industry
  • VIGL Biotechnology: Pharmaceutical Preparations
  • SNCR EDP Services
  • Sector
  • VIGL Health Care
  • SNCR Technology
  • Exchange
  • VIGL Nasdaq
  • SNCR Nasdaq
  • Market Cap
  • VIGL 134.9M
  • SNCR 73.5M
  • IPO Year
  • VIGL 2022
  • SNCR 2006
  • Fundamental
  • Price
  • VIGL $7.99
  • SNCR $7.36
  • Analyst Decision
  • VIGL Buy
  • SNCR Strong Buy
  • Analyst Count
  • VIGL 7
  • SNCR 1
  • Target Price
  • VIGL $8.00
  • SNCR $13.00
  • AVG Volume (30 Days)
  • VIGL 1.6M
  • SNCR 137.1K
  • Earning Date
  • VIGL 08-12-2025
  • SNCR 08-05-2025
  • Dividend Yield
  • VIGL N/A
  • SNCR N/A
  • EPS Growth
  • VIGL N/A
  • SNCR N/A
  • EPS
  • VIGL N/A
  • SNCR N/A
  • Revenue
  • VIGL N/A
  • SNCR $172,842,000.00
  • Revenue This Year
  • VIGL N/A
  • SNCR $2.07
  • Revenue Next Year
  • VIGL N/A
  • SNCR $5.42
  • P/E Ratio
  • VIGL N/A
  • SNCR N/A
  • Revenue Growth
  • VIGL N/A
  • SNCR 4.64
  • 52 Week Low
  • VIGL $1.31
  • SNCR $6.00
  • 52 Week High
  • VIGL $8.00
  • SNCR $15.46
  • Technical
  • Relative Strength Index (RSI)
  • VIGL 88.87
  • SNCR 55.92
  • Support Level
  • VIGL $7.86
  • SNCR $6.00
  • Resistance Level
  • VIGL $7.96
  • SNCR $7.67
  • Average True Range (ATR)
  • VIGL 0.02
  • SNCR 0.41
  • MACD
  • VIGL -0.18
  • SNCR 0.20
  • Stochastic Oscillator
  • VIGL 93.33
  • SNCR 81.44

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

Share on Social Networks: